Activation of LYN kinase is associated with imatinib-resistance in CML patients

User rating: not rated yet

Activation of LYN kinase is associated with resistance to imatinib (Gleevec) in patients with chronic myelogenous leukemia (CML), researchers report in the June 24 online issue of the Journal of the National Cancer Institute.